COMMUNIQUÉS West-GlobeNewswire

aTyr Pharma to Participate in September Conferences
18/09/2019
SAN DIEGO, Sept. 18, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
First Patient Enrolled in Landmark CareDx OKRA Registry
18/09/2019
CareDx drives best in class 4,000 transplant patient registry with KOAR and OKRA BRISBANE, Calif., Sept. 18, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the [...]
Biogen Advances Spinal Muscular Atrophy (SMA) Clinical Research with New Study Evaluating a Higher Dose of SPINRAZA® (nusinersen) and Additional Data in a Broad Range of Patients
18/09/2019
DEVOTE trial to evaluate safety and even greater efficacy of a higher dose of SPINRAZA in the treatment of SMA; well-established safety profile supports exploration of potential benefits Long-term data from the SHINE [...]
Paralympic Skier Danelle Umstead Teams Up with Spark Therapeutics to Help People Living with Inherited Retinal Diseases (IRDs) Access Genetic Testing
18/09/2019
Paralympic, blind skier declared Eye Want 2 Know ® and pursued genetic testing to uncover the genetic cause of her retinitis pigmentosa (RP), an IRD Spark Therapeutics unveils enhanced ID YOUR IRD ® genetic test for [...]
Auxly and Kindred Announce Canadian Brokerage Agreement
18/09/2019
VANCOUVER, British Columbia, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly ") and Kindred Partners Inc. (“ Kindred ”) are pleased to announce that they have entered into a brokerage [...]
AgraFlora Organics Awarded Cannabis Research License from Health Canada
18/09/2019
VANCOUVER, British Columbia, Sept. 18, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
AgraFlora Organics obtient une licence de recherche sur le cannabis de la part de Santé Canada
18/09/2019
VANCOUVER, Colombie-Britannique, 18 sept. 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) une société internationale de [...]
MiniMed™ 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended Targets
18/09/2019
DUBLIN, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions today announced real-world clinical outcomes on European patients for the MiniMed™ [...]
MiniMed™ 670G System European Real-World Data Shows 73% Time in Range, Beyond Recommended Targets
18/09/2019
DUBLIN, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions today announced real-world clinical outcomes on European patients for the MiniMed™ [...]
Chi-Med Highlights Oral Presentations at 2019 CSCO Annual Meeting
18/09/2019
LONDON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) shares additional analyses from three completed and ongoing clinical studies of fruquintinib and savolitinib at [...]
Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient Outcomes
18/09/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Announces Publication of Editorial in Future Microbiology Advocating for Innovation in Antibiotic Development to Drive Stewardship Focus on Improving Patient [...]
Saniona reports positive Tesomet Phase 2a clinical results in adolescent patients with Prader-Willi syndrome
18/09/2019
PRESS RELEASE September 18, 2019 Tesomet was safe and well tolerated in growing adolescent patients with PWS at both tested doses Reduction in body weight and improvement of BMI observed at the high dose with [...]
Curetis Reports Financial Results for the First Six Months of 2019
18/09/2019
- Strategic transaction to combine businesses with OpGen Inc. - Revenues increased by approximately 35% year-on-year - Progressing regulatory product approvals in the U.S. and China Amsterdam, the Netherlands, [...]
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
18/09/2019
There are currently no U.S. FDA-approved medicines for lupus nephritis The designation is based on the results of the phase II NOBILITY study that showed Gazyva, in combination with standard of care, helped more people [...]
Translate Bio Announces Pricing of Public Offering of Common Stock
18/09/2019
LEXINGTON, Mass., Sept. 17, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
IGM Biosciences Announces Pricing of Initial Public Offering
18/09/2019
MOUNTAIN VIEW, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced the pricing of its initial public offering of 10,937,500 shares of its common stock at a price to the public [...]
NewLink Genetics Announces FDA Accepts Partnered Biologics License Application (BLA) and Grants Priority Review for Ebola Vaccine V920 (rVSV∆G-ZEBOV-GP)
17/09/2019
AMES, Iowa, Sept. 17, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that the U.S. Food and Drug Administration (FDA) has accepted Merck’s Biologics License Application (BLA) and [...]
ERYTECH fait le point sur ses activités et publie ses résultats semestriels 2019
17/09/2019
Conférence téléphonique et webcast le mercredi 18 septembre à 14h30 (heure de Paris) Déroulement comme prévu de l’étude TRYbeCA1 de Phase 3 avec eryaspase dans le traitement en seconde ligne du cancer du pancréas [...]
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2019
17/09/2019
Conference call and webcast on Wednesday, September 18 at 2:30 pm CET/8:30 am EDT TRYbeCA1, Phase 3 trial for eryaspase in second line pancreatic cancer, progressing on plan Immune modulation collaboration entered into [...]

Pages